Roderich E. Schwarz MD

Roderich Schwarz

Roderich E. Schwarz
MD

Contact Information
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (214) 537-0498
roderich@buffalo.edu



Professional Summary:

I was exposed to the field of surgery through my ancestry, as my grandfather and great-grandfather were surgeons. I knew that I wanted to be a surgeon from an early age, and during medical school I always had the surgical field in mind. Helping patients through gastrointestinal cancer treatments and operations has been my passion and focus for almost 40 years. A cancer diagnosis is a tremendous challenge for anyone. Within a single day, it can turn someone's world upside down. Being able to help patients who are in that situation, both as a physician and as a surgeon, is very important to me. Cancer treatment is not only about treating the tumor in the best possible way, but helping the patient and the family cope with the situation and guiding them through it.

I began my medical education in Germany and continued my training, research and clinical work in the United States at various well-respected cancer centers, including the University of Pittsburgh, Memorial Sloan-Kettering Cancer Center, City of Hope in California, the Cancer Institute of New Jersey, the Simmons Comprehensive Cancer Center at UT Southwestern in Texas and most recently at Indiana University with the Goshen Center for Cancer Care, before coming to Buffalo, NY. After having worked at a total of five National Cancer Institute-designated comprehensive cancer centers, I consider it a true privilege to now hold a leadership role at a center like Roswell Park that set the model for other cancer centers to follow over a century ago.

My clinical interest is in pancreatic, hepatobiliary and upper GI tract cancer. My laboratory-based translational activities focus on experimental combination therapy of pancreatic and gastric cancer. I am a member of 13 scientific organizations, including the American College of Surgeons (ACS), American Association for Cancer Research (AACR), Society of Surgical Oncology (SSO), Americas Hepato-Pancreato-Biliary Association (AHPBA) and Society of University Surgeons (SUS), and have served as committee member or chair and as executive council member on several of these. I am also recognized as an exceptional clinician member of the "Best Doctors in America" and "America's Top Surgeons" databases, and as an outstanding teacher through several academic teaching awards.

Employment:

  • Professor, Surgery, Roswell Park Cancer Institute (2018-present)
  • Professor of Surgery, Surgery, Indiana University, School of Medicine (2013-present)
  • Medical Director, Goshen Center for Cancer Care (2013–2018)
  • Mark and Jane Gibson Distinguished Professor of Cancer Research, UT Southwestern Medical School (2008–2013)
  • Division of Surgical Oncology, UT Southwestern Simmons Comprehensive Cancer Center, UT Southwestern Medical School (2007–2013)

Awards and Honors:

  • Traveller's Grant Award to the 101st Annual Congress (2001)
  • Surgical Oncology Fellows Operative Teaching Award (1999)
  • Poster of Distinction award (1998)
  • NIH-K12 Fellow Research Award (1998)
  • Best Poster Presentation Award (1995)
  • Deutsche Forschungsgemeinschaft (DFG) (1987)
  • Clinical Fellowship Abroad award (1985)
  • The Welcome Trust: British subinternship exchange travel award (1983)


Journal Articles:

See all (100 more)

Books and Book Chapters:

  • Nelson, RA, Smith, DD, Schwarz RE. Epidemiology and Staging of Upper Gastrointestinal Cancer, Chapter 84. 2018.
  • Schwarz RE. Esophagogastric Junction Cancer: Definition, Staging Aspects, Therapeutic Implications. Chapter 92, Upper Gastrointestinal Cancer Section. 2018.
  • von Holzen, UW, Mansour, JC, Schwarz RE. Multimodality Therapy of Gastric Cancer: Western Experience. Chapter 100, Upper Gastrointestinal Cancer Section. 2018.
  • von Holzen, UW, Mansour, JC, Schwarz RE. Surgical emergencies in the thrombocytopenic or anticoagulated cancer patient, Chapter 4. 2016.
  • Ostapoff, KT, Awasthi, N, Dellinger, M, Brekken, RD, Schwarz RE. Modeling pancreatic cancer in vivo.. 2014.
  • Schwarz RE. Standards for Surgical Therapy of Gastric Cancer. 2014.
  • Konduri, S, Schwarz RE. Estrogen receptor implications in human pancreatic cancer.. 2010.
  • Blanke, CD, Citrin, D, Schwarz RE. Gastric Cancer, chapter 10. 2010.
  • Blanke, CD, Citrin, D, Schwarz RE. Gastric Cancer, Chapter 13. 2008.
  • August, DA, Kearnery, T, Schwarz RE. General oncologic surgical emergencies. Chapter 73. 2006.
  • Bonin, SR, Schwarz RE, Blanke, CD, Coia, LR, Hoff, PM. Gastric Cancer Chapter 13. 2001.
  • Schwarz RE, Karpeh, MS, Brennan, MF. Surgical management of gastric cancer: the Western experience.. 1999.
  • Schwarz RE, Grannis, FW. Thoracoscopic lung resections in the treatment of pulmonary malignancies.. 1998.
  • Coia, LR, Bonin, SR, Diaz-Canton, EA, Pazdur, R, Schwarz RE. Gastric Cancer-chapter 5. 1998.
  • Harrison, LE, Schwarz RE, Karpeh, MS, Brennan, MF. Total gastrectomy is not necessary for proximal gastric cancer.. 1997.
  • Schwarz RE, Klimstra, DS, Turnbull, ADM. Gastric cancer masqueraded by metastatic breast cancer: a differential diagnostic challenge.. 1997.
  • Schwarz RE, Karpeh, MS, Brennan, MF. Impact of complications on hospitalization and survival after operative treatment of gastric cancer in elderly patients.. 1997.
  • Schwarz RE, Posner, MC. Tumor Biology. 1994.
  • Schwarz RE, Felgar, RE, Hiserodt, JC. Successful adoptive immunotherapy of established lung and liver metastases with highly purified IL-2 activated natural killer cells (ALAK cells).. 1990.
  • Schwarz RE. Ssurface structures involved in tumor cell recognition by fresh and IL-2 activated natural killer cells. 1988.
  • Schwarz RE. Laminin-like p48: a surface structure involved in target cell recognition by non-MHC-restricted cytotoxic effector cells.. 1988.
  • Minarich, MJ, von Holzen, UW, Schwarz RE. Surgical therapy and appropriate lymphadenectomy for GE junction cancer...
See all (12 more)

Evaluative Studies and Case Reports:

See all (17 more)

Presentations:

  • "Nintedanib, a triple angiokinase inhibitor, augments chemotherapy response in preclinical models of gastric cancer" 13th International Gastric Cancer Association Meeting (2019)
  • "Enhancing nab-paclitaxel response with merestinib, a c-met/VEGFR pathway inhibitor, in gastric cancer preclinical models" Eighth Annual Cancer Research Day, Notre Dame University, Harper Cancer Research Institute (2019)
  • "Galunisertib, a novel TGF-b receptor 1 inhibitor, in conjunction with standard chemotherapy for pancreatic ductal adenocarcinoma therapy" Eighth Annual Cancer Research Day, Harper Cancer Research Institute (2019)
  • "Inhibition of the aurora kinase A pathway enhances nab-paclitaxel/gemcitabine chemotherapy response in in vitro pancreatic cancer" Eighth Annual Cancer Research Day, Notre Dame, University, Harper Cancer Research Institute (2019)
  • "MET activation mediates lapatinib resistance in experimental esophageal adenocarcinoma" Eighth Annual Cancer Research Day, Notre Dame University, Harper Cancer Research Institute (2019)
  • "Targeting PI3K/AKT and Ras/Raf/ERK pathways augments standard chemotherapy response in pancreatic cancer" Eighth Annual Cancer Research Day, Notre Dame University, Harper Cancer Research Institute (2019)
  • "An Unusual Hepatic Pseudotumor Due to Nodular Elastosis of the Liver" Americans Hepato-Pancreato-Biliary Association (AHPBA) 2019 Annual Meeting (2019)
  • "Augmentation of nab-paclitaxel chemotherapy response by targeted inhibition of FGF/PDGF/VEGF signaling in preclinical gastric cancer models" American Association for Cancer Research Annual Meeting (2019)
  • "Augmenting nab-paclitaxel-based chemotherapy response through targeted inhibition of BET proteins in preclinical models of pancreatic cancer" American Association for Cancer Research Annual Meeting. (2019)
  • "Isolated Intrahepatic Mass: Who Would Biopsy, Who Would Resect?" Americas Hepato-Pancreato-Billiary Association (AHPBA) 2019 Annual Meeting (2019)
  • "MET activation mediates lapatinib resistance in experimental esophageal adenocarcinoma" American Association for Cancer Research Annual Meeting (2019)
  • "Pre-event predictors for unsuccessful postoperative transition of care after major abdominal oncologic operations" SSo 2019 Annual Cancer Symposium Society of Surgical Oncology (2019)
  • "Structured evaluation of clinical risk scores to predict morbidity after HPB operations" Americans Hepato-Pancreato-Biliary Association (AHPBA) 2019 Annual Meeting (2019)
  • "Technical pearls for operative management of liver conditions" Buffalo - Toronto Surgical Oncology Fellowship Meeting Presentation,, Roswell Park Comprehensive Cancer Center (2019)
  • "A celiotomy closure technique with minimized risk for incisional hernia formation" 14th Annual Academic Surgical Congress (2019)
  • "A structured evaluation of preoperative risk assessment tools for visceral oncologic resections" 14th Annual Academic Surgical Congress (2019)
  • "Surgical quality aspects for gastrointestinal cancer care." Third Zhujiang International Conference on Gastrointestinal Oncology and 2nd International Medical Forum,, The American Chinese Medical Association, The Seventh Affiliated Hospital of Sun Yat-sen University (2018)
  • "Liver resections for malignancy: technical considerations." Roswell Park Department of Surgical Oncology Fellow's Presentation, Roswell Park Comprehensive Cancer Center (2018)
  • "A celiotomy closure technique with minimized risk for incisional hernia formation" Midwest Surgical Association 2018 Annual Meeting (2018)
  • "A structured evaluation of preoperative risk assessment tools for visceral resections in a community-based surgical practice" Midwest Surgical Association 2018 Annual Meeting (2018)
  • "On the quality of quality data reports" Midwest Surgical Association 2018 Annual Meeting (2018)
  • "Enhancing cytotoxic chemotherapy response through targeted BET bromodomain inhibition in preclinical pancreatic cancer models" Indiana Medical Student Program for Research and Scholarship IMPRS Meeting (2018)
  • "Multidisciplinary consideration for GE junction cancers." Toronto D2 Lymph Node Dissection Surgical Skill Course,, Sunnybrook Health Sciences Center, University of Toronto (2018)
  • "Pitfalls and cautionary tales for extended lymphadenectomy." Toronto D2 Lymph Node Dissection Surgical Skill Course,, Sunnybrook Health Sciences Center,, University of Toronto, (2018)
  • "A case-based approach to the current management of metastatic colorectal cancer." Weiss Memorial Hospital Educational Conference (2018)
  • "Multidisciplinary therapy aspects for colorectal cancer liver metastasis." Oncology Conference, Multidisciplinary therapy aspects for colorectal cancer liver metastasis. (2018)
  • "Special considerations for GE junction cancers." Upper gastrointestinal cancer international mini-symposium,, IU School of Medicine - SB, Goshen Center for Cancer Care and Harper Cancer Research Institute, (2018)
  • "A structured evaluation of preoperative risk assessment tools for visceral resections in a community-based surgical oncology practice" ACS Chapter Annual Meeting (2018)
  • "Cotargeting PI3K and MAPK signaling enhances nab-paclitaxel-based chemotherapy response in preclinical models of pancreatic cancer" 7th Annual Harper Cancer Research Day, Notre Dame University (2018)
  • "Enhancement of nab-paclitaxel response by inhibition of insulin-like growth factor signaling in experimental esophageal adenocarcinoma" American Association for Cancer Research Annual Meeting (2018)
  • "Enhancing cytotoxic chemotherapy response through targeted BET bromodomain inhibition in preclinical models of pancreatic cancer" 7th Annual Harper Cancer Research Day (2018)
  • "Quality metrics for GI cancer care: experience and challenges." Indiana ACS Chapter meeting 2018, (2018)
  • "Synergistic effects of foretinib with lapatinib in MET and HER2 co-activated experimental esophageal adenocarcinoma" American Association for Cancer Research Annual Meeting (2018)
  • "Targeted inhibition of FGF/PDGF/VEGF signaling enhances nab-paclitaxel response in preclinical models of gastric cancer" 7th Annual Harper Cancer Research Day, Notre Dame University (2018)
  • "The dual c-MET/VEGFR2 inhibitor foretinib augments chemotherapy response in preclinical models of gastric cancer" American Association for Cancer Research Annual Meeting (2018)
  • "Therapeutic efficacy on anti-MMP9 antibody in combination with standard cytotoxic therapy in preclinical models of pancreatic cancer" American Association for Cancer Research Annual Meeting (2018)
  • "A comparison of two-step retrogastric lymphadenectomy versus en bloc dissection during resection for gastroesophageal malignancy" SSO 2018 Annual Cancer Symposium, Society of Surgical Oncology (2018)
  • "Pelvic malignancies: epidemiology, screening, diagnosis, specialty treatment and symptom management." Goshen Center for Cancer Care Oncology Update Symposium,, Elcona Country Club (2017)
  • "Combined inhibition of MAPK and PI3K signaling augments standard chemotherapy in preclinical models of pancreatic cancer" AACR-NCI-EORTC international Conference on Molecular Targets and Cancer Therapeutics (2017)
  • "Dual targeting of MAPK and PI3K pathways augments standard chemotherapy response in preclinical models of pancreatic cancer" Notre Dame University Life Science Symposium (2017)
  • "Optimizing pancreatic cancer therapy outcomes in the future: quality aspects and research directions." West Michigan Cancer Center GI Cancer Symposium (2017)
  • "A comparison of two-step retrogastric lymphadenectomy versus en bloc dissection during resection for gastroesophageal malignancy" Midwest Surgical Association 2017 Annual Meeting (2017)
  • "Cancer research and its implication for clinical care." Goshen Rotary Club presentation (2017)
  • "Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care within a surgical oncology practice" Midwest Surgical Association 2017 Annual Meeting (2017)
  • "Two-stage palliative multivisceral retroperitoneal resection to control unmanageable duodenal bleed due to recurrent paraganglioma" Midwest Surgical Association 2017 Annual Meeting (2017)
  • "Experience with antistromal therapy of experimental pancreatic cancer." Gastrointestinal Cancer Conference,, Carle Cancer Center, University of Illinois Medical College (2017)
  • "Institutional variants for lymph node counts after pancreatic resections" 51st Annual Pancreas Club Meeting (2017)
  • "A comparison of two-step retrogastric lymphadenectomy versus en bloc dissection during resection for gastroesophageal malignancy in a Western practice setting" 12th International Gastric Cancer Association Meeting (2017)
  • "A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma" American Association for Cancer Research Annual Meeting (2017)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the U.S." 12th International Gastric Cancer Association Meeting (2017)
  • "Clinical trends and effects on quality metrics for surgical gastroesophageal cancer care within an oncologic practice in the U.S." 12th International Gastric Cancer Association Meeting (2017)
  • "Enhancing Cytotoxic Chemotherapy Response through Targeted Inhibition of Angiogenesis in Preclinical Models of Cholangiocarcinoma" 6th Annual Harper Cancer Research Day, Notre Dame University (2017)
  • "Enhancing nab-paclitaxel response by targeted inhibition of FGF/PDGF/VEGF signaling pathways in preclinical models of gastric cancer" 12th International Gastric Cancer Association Meeting (2017)
  • "Foretinib, a c-Met / VEGFR inhibitor, augments chemotherapy response in preclinical models of gastric cancer" 12th International Gastric Cancer Association Meeting (2017)
  • "Foretinib, a c-Met / VEGFR inhibitor, augments chemotherapy response in preclinical models of gastric cancer" 6th Annual Harper Cancer Research Day, Notre Dame University (2017)
  • "Gastric cancer in the U.S.: lessons learned in the past 20 years" Department of Surgery Conference Visiting Professor Lecture,, Sun Yat Sen University, (2017)
  • "Superior therapeutic efficacy of nanoparticle albumin bound paclitaxel over cremophor-bound paclitaxel in experimental esophageal carcinoma" American Association for Cancer Research Annual Meeting (2017)
  • "Targeted inhibition of PI3K and MAPK signaling pathways enhances standard chemotherapy response in preclinical pancreatic cancer models" 6th Annual Harper Cancer Research Day, Notre Dame University (2017)
  • "Trametinib, a MEK inhibitor, augments nab-paclitaxel based chemotherapy response in preclinical models of pancreatic cancer" American Association for Cancer Research Annual Meeting (2017)
  • "A case-management approach to the current management of metastatic colorectal cancer." Halifax Hospital Medical Education (2017)
  • "Gastrointestinal cancer, sarcoma and melanoma." Oncology Module Lecture,, Second -Year Medical Student Lecture Series,, Indiana University School of Medicine, South Bend, (2017)
  • "The surgical oncologist as leader in cancer care." Roswell Park Memorial Institute Surgical Grand Rounds, (2016)
  • "Colorectal cancer liver metastases: the interface between systemic therapy and curative intent resection." Tzu-Chi University Hospital, Department of Surgery, (2016)
  • "Options for conversion therapy in advanced colorectal cancer liver metastases." Taipei Veterans' General Hospital,, Division of Colon and Rectal Surgery,, National Yang-Ming University (2016)
  • "Role of antiangiogenic therapy in first line treatment of potentially resectable metastatic colorectal cancer patients." Lunch Symposium, 2016 International Colorectal Surgery Forum, (2016)
  • "The role of Avastin in the treatment of first- through second line metastatic colorectal cancer." Medical Oncology clinical presentation, (2016)
  • "Enhancing pancreatic cancer chemotherapy response by targeted inhibition of TGFβ induced tumorigenic signaling" AACR Special Conference on Pancreatic Cancer (2016)
  • "Institutional variants for lymph node counts after pancreatic resections" Midwest Surgical Association 2016 Annual Meeting (2016)
  • "Significant vascular challenges during and after pancreatic resection." Midwest Surgical Association 2016 Annual Meeting (2016)
  • "The impact of immediate breast reconstruction after mastectomy on time to first adjuvant treatment in women with breast cancer" Midwest Surgical Association 2016 Annual Meeting (2016)
  • "The impact of immediate breast reconstruction after mastectomy on time to first adjuvant treatment in women with breast cancer" Midwest Surgical Association 2016 Annual Meeting (2016)
  • "Adding targeted inhibition of PI3K and MAPK signaling pathways to standard chemotherapy in experimental pancreatic cancer" 50th Annual Pancreas Club meeting (2016)
  • "Augmentation of response to chemotherapy by MEK inhibition in pancreatic cancer." 5th Annual Harper Cancer Research Day, Notre Dame University (2016)
  • "C1P Mediates Adhesion and Migration of Pancreatic Cancer Stem Cells" 5th Annual Harper Cancer Research Day, Notre Dame University (2016)
  • "Current state and future direction for the Goshen Center for Cancer Care." IU Health Goshen Staff Meeting Presentation, (2016)
  • "Enhancing standard chemotherapy response by targeted inhibition of MAPK signaling pathways in experimental pancreatic cancer" American Association for Cancer Research Annujal Meeting (2016)
  • "Establishing a novel peritoneal carcinomatosis mouse model for survival outcome assessment of esophageal adenocarcinoma" 5th Annual Harper Cancer Research Day, Notre Dame University (2016)
  • "Metastatic colorectal cancer treatment strategies." Maryland Oncology Hematology Practice presentation (2016)
  • "Therapeutic potential of the cyclin- dependent kinase inhibitor on c-Myc overexpressing esophageal adenocarcinoma" American Association for Cancer Research Annual Meeting (2016)
  • "Multidisciplinary options for metastatic colorectal cancer therapy" Little Company of Mary Hospital and Health Care Centers, (2016)
  • "Reported quality metrics in published esophageal resection series" Society of Surgical Oncology 68th Annual Cancer Symposium (2016)
  • "Adding targeted inhibition of PI3K and MAPK signaling pathways to standard chemotherapy in experimental pancreatic cancer" 2016 Gastrointestinal Cancers Symposium (2016)
  • "Systemic and local therapy options for colorectal cancer liver metastases." Erie Oncology Practice update, (2015)
  • "Primary care and oncologic specialty care: quality aspects across the cancer care continuum." Goshen Center for Cancer Care Oncology Update Symposium, Elcona Country Club (2015)
  • "An evidence based approach to support the role of bevacizumab in the first- through second-line therapy setting of metastatic colorectal cancer." Grand Rapids Oncology dinner meeting, (2015)
  • "Antiangiogenic combination therapy of metastatic colorectal cancer." Andrew and Patel Oncology Associates practice presentation, (2015)
  • "From vascular biology to cardiopulmonary disease and cancer: a couple‘s (e)map of translational medicine." Combined presentation, Goshen College Science Speaker Series, (2015)
  • "Antiangiogenic combination therapy for colorectal cancer metastasis in multiple lines." Medical Oncology Education Presentation (2015)
  • "Molecular subtype classification of gastric adenocarcinoma cell lines reveal incomplete spectrum of clinical representation" IU Student Research Competition (2015)
  • "Quality aspects of cancer care." Auburn Family Physicians Roundtable presentation,, DeKalb Hospital (2015)
  • "Targeted inhibition of MAPK and PI3K signaling pathways enhances chemotherapy response in pancreatic cancer" Indiana University Simon Cancer Center Research Day (2015)
  • "Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral procedures" Midwest Surgical Association 2015 Annual Meeting (2015)
  • "Multidisciplinary approach to liver metastases from colorectal cancer." Oncology practice symposium, (2015)
  • "Colorectal liver metastases unresectable at first: can we offer curative treatment?" A.C. Camargo Cancer Center Annual Postgraduate Course, Sao (2015)
  • "Individualized neoadjuvant treatment in gastroesophageal tumors." A.C. Camargo Cancer Center Annual Postgraduate Course (2015)
  • "Laparoscopic gastrectomy for cancer: US experience." 11th International Gastric Cancer Congress, (2015)
  • "Predictors for peritoneal recurrence of gastric cancer." 11th International Gastric Cancer Congress, Sao (2015)
  • "Curative and non-curative treatment options for colorectal cancer liver metastases." Gastrointestinal oncology education event, (2015)
  • "Pancreas stump closure technique affects pancreatic fistula rate after radical distal pancreatectomy" 49th Annual Pancreas Club meeting and Society for Surgery of the Alimentary Tract (SSAT) meeting (2015)
  • "A case-based approach to colorectal liver metastasis therapy." Medical Oncology educational presentation (2015)
  • "BMS-754807, a small-molecule inhibitor of IGF-1R/IR, enhances cytotoxic therapy response in pancreatic cancer" 4th Annual Harper Cancer Research Day, Notre Dame University (2015)
  • "C1P mediates proliferation and migration of pancreatic cancer stem cells" 4th Annual Harper Cancer Research Day, Notre Dame University (2015)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the US" Indiana ACS Chapter meeting 2015, (2015)
  • "Colorectal cancer liver metastasis." Oncology educational dinner (2015)
  • "Enhancing chemotherapy response in pancreatic cancer through targeted inhibition of MAPK and PI3K signaling pathways" 4th Annual Harper Cancer Research Day, Notre Dame University (2015)
  • "Enhancing nab-paclitaxel antitumor activity through addition of BMS-754807, a small-molecule inhibitor of IGF1R/IR, in experimental pancreatic cancer" American Association for Cancer Research Annual Meeting (2015)
  • "VirGA-C: a comprehensive sequencing pipeline with cancer-specific applications" 4th Annual Harper Cancer Research Day, Notre Dame University (2015)
  • "Complex surgical oncology cases within a multidisciplinary treatment approach." Ft. Wayne Hematology-Oncology Monthly Meeting, (2015)
  • "Overview of metastatic colorectal cancer treatment" Winston-Salem Oncology dinner meeting, (2015)
  • "Selective internal radiotherapy: what is the role in unresectable liver metastases? Defining roles for novel techniques in HPB oncology session," Society of Surgical Oncology 68th Annual Cancer Symposium, (2015)
  • "Antiangiogenic therapy for advanced colorectal cancer." Franciscan Physician Network Educational Presentation (2014)
  • "A patient journey with colorectal cancer liver metastasis." (2014)
  • "Liver metastasis from colorectal cancer: multimodality treatment options." John H. Stroger Hospital of Cook County Tumor Board Conference, (2014)
  • "Multidisciplinary treatment for colorectal cancer liver metastases." Oncology Practice Rounds (2014)
  • "Perioperative systemic therapy for liver metastases from colorectal cancer." Mercy Health System Cancer Center (2014)
  • "Surgical oncology: a specialty report" West Michigan Cancer Center CME Event, (2014)
  • "Systemic treatment options for metastatic colorectal cancer with liver involvement." (2014)
  • "Toxicity and efficacy results from a Phase I dose-escalation study of single-fraction stereotactic irradiation for liver metastases" 56th Annual ASTRO Meeting (submitted) (2014)
  • "Experience with a simple clamp-crush technique devoid of other devices for liver resections in a surgical oncology practice" Midwest Surgical Association 2014 Annual Meeting (2014)
  • "Experience with a simple clamp-crush technique devoid of other devices for liver resections in a surgical oncology practice." Midwest Surgical Association 2014 Annual Meeting, (2014)
  • "Journey of a patient with gastrointestinal stromal tumor." Novartis Educational Presentation, (2014)
  • "Current management of gastric cancer." Society of Surgery of the Alimentary Tract (SSAT) Maintenance of Certification Course, Digestive Disease Week, Current Management of Benign and Malignant Foregut Diseases (2014)
  • "Role of Endothelial Monocyte Activating Polypeptide in bronchopulmonary dysplasia," Senior Pediatric Fellow's Research Day, UT Southwestern (2014)
  • "Access to quality cancer care: challenges and opportunities." Annual Meeting of the Indiana Chapter of the American College of Surgeons (2014)
  • "Antitumor activity of nintedanib (BIBF 1120), a triple angiokinase inhibitor, in combination with gemcitabine in experimental pancreatic cancer" American Association for Cancer Research Annual Meeting (2014)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the US" 3rd Annual Harper Cancer Research Day, Notre Dame University (2014)
  • "Enhancing chemotherapy response by nintedanib, a triple angiokinase inhibitor, in experimental pancreatic cancer" 3rd Annual Harper Cancer Research Day, Notre Dame University (2014)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the US" Society of Surgical Oncology 67th Annual Cancer Symposium (2014)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the US" Society of Surgical Oncology 67th Annual Cancer Symposium (2014)
  • "Liver resection for metastatic disease after Y90 radioembolization: a case series with long-term follow-up" Society of Surgical Oncology 67th Annual Cancer Symposium (2014)
  • "Management challenges in metastatic colorectal cancer: case presentations." Butler Regional Cancer Center education event (2014)
  • "Multidisciplinary therapy of colorectal cancer liver metastases." Cancer Center clinical rounds presentation (2014)
  • "Multimodality treatment of GE junction carcinoma. Expert practice in GE junction carcinoma," Society of Surgical Oncology 2014 Cancer Symposium (2014)
  • "Learning by trial: recent successes and failures." Mini-symposium on systemic therapy for pancreatic cancer: an update,, Americas Hepato Pancreato Biliary Association (AHPBA) 14th Annual Meeting, (2014)
  • "Role of Endothelial Monocyte Activating Polypeptide in bronchopulmonary dysplasia," Southern Society of Pediatric Research (2014)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the US" Gastrintestinal Cancers Symposium (ASCO-GI) (2014)
  • "Approved treatments and clinical trials for pancreatic cancer." The 1st Pancreatic Cancer Research Symposium,, Notre Dame University, Harper Cancer Research Institute (2013)
  • "Multidisciplinary treatment of colorectal cancer metastases." Beavercreek, Ohio, Oncology Conference, (2013)
  • "Combination therapy approaches to challenging cases of metastatic colorectal cancer." Kankakee Hematology-Oncology Group presentation, (2013)
  • "Metastatic colorectal cancer: a case-based approach." Louisville Oncology Group presentation, (2013)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the U.S." JSGS-SSO co-sponsored symposium on esophagogastric junction cancer, Japanese Society of Gastrointestinal Surgeons Annual Meeting, (2013)
  • "Changing patterns in presentation and therapy of esophagogastric junction cancers in the US" Japanese Society of Gastrointestinal Surgeons Annual Meeting, JSGSSSO Co-sponsored symposium on esophagogastric junction cancer (2013)
  • "Multidisciplinary aspects of esophagogastric junction cancer therapy." Invitational lecture, Department of Surgery, Keio University, (2013)
  • "Adjuvant treatment strategies for high-risk resected GI stromal tumors." Carson City Oncology group presentation (2013)
  • "Multidisciplinary therapy of c-kit positive GISTs" Oncology service dinner presentation, (2013)
  • "Risk definition methods for resected GI stromal tumors." Oncology Group Poster Presentation, (2013)
  • "Risk definition methods for resected GI stromal tumors." Oncology Group Poster Presentation (2013)
  • "Role of combination systemic therapies in patients with resectable colorectal cancer metastases." Genentech Key Opinion Leader Panel (2013)
  • "Antiangiogenic therapy for metastatic colorectal cancer" Fort Wayne Oncology presentation (2013)
  • "Endothelial monocyte-activating polypeptide II (EMAP II) induces bronchopulmonary dysplasia (BPD)-like phenotype in uninjured mice, and hyperoxia-induced BPD is improved by an EMAP II blocking antibody" 2013 Pediatric Academic Societies (PAS) Annual Meeting (2013)
  • "Hispanic patients with melanoma present with advanced disease" 15th Annual UT Southwestern Surgical Research Forum (2013)
  • "Plexiform neurofibromatosis of the li" 15th Annual UT Southwestern Surgical Research Forum (2013)
  • "The impact of preoperative therapy for patients with gastroesophageal adenocarcinoma undergoing resection" 15th Annual UT Southwestern Surgical Research Forum (2013)
  • "Addition of antiangiogenic agents enhances nab-paclitaxel antitumor activity in experimental pancreatic cancer" American Asssociation for Cancer Research Annual Meeting (2013)
  • "Complex case examples of multimodality cancer therapy" Merrillville Oncology Presentation (2013)
  • "A programmatic approach to complex cancer care." Noble County Medical Society Meeting, (2013)
  • "Advancing pancreatic cancer combination therapy: a clinician's perspective." Harper Cancer Research Institute Research Seminar (2013)
  • "Bevacizumab in the combination therapy of metastatic colorectal cancer." Doctors' Hospital Weekly Tumor Board presentation (2013)
  • "Comparative benefits of nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer" Society of Surgical Oncology 66th Annual Cancer Symposium. (2013)
  • "COX-2 inhibition with apricoxib mediates response to chronic anti-VEGF therapy" Society of Surgical Oncology 66th Annual Cancer Symposium. (2013)
  • "Establishment of multidisciplinary hepatocellular carcinoma clinic is associated with better clinical outcome" Society of Surgical Oncology 66th Annual Cancer Symposium. (2013)
  • "Heparanase inhibition reduces vascular function and collagen deposition and potently inhibits tumor growth and metastasis in murine models of pancreatic cancer" Society of Surgical Oncology 66th Annual Cancer Symposium (2013)
  • "Inhibition of stromal TGFβR2 inhibits pancreatic cancer growth and metastasis in vivo" Society of Surgical Oncology 66th Annual Cancer Symposium. (2013)
  • "Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer" Society of Surgical Oncology 66th Annual Cancer Symposium. (2013)
  • "The quality of our quality reporting: metrics of cancer care following pancreatoduodenectomy" Society of Surgical Oncology 66th Annual Cancer Symposium (2013)
  • "Theses on multidisciplinary care of pancreatic cancer." Medical Staff Education Conference,, IU Health Goshen Medical Center (2013)
  • "Warfarin blocks Gas6mediated Axl activation required for pancreatic tumor EMT and metastasis" Society of Surgical Oncology 66th Annual Cancer Symposium. (2013)
  • "A susceptibility model for venous thromboembolism after major hepatic resection" Americas Hepato Pancreato Biliary Association 13th Annual Meeting (2013)
  • "Hispanic patients with melanoma present with advanced disease" 52nd Annual Meeting of the North Texas Chapter of the American College of Surgeons (2013)
  • "Initiation and early experience of robotic assisted laparoscopic resection of rectal cancer" 52nd Annual Meeting of the North Texas Chapter of the American College of Surgeons (2013)
  • "The impact of preoperative therapy for patients with gastroesophageal adenocarcinoma undergoing resection." 52nd Annual Meeting of the North Texas Chapter of the American College of Surgeons (2013)
  • "Traditional methods of hepatotomy: crush-clamp and CUSA techniques." Americas Hepato Pancreato Biliary Association 13th Annual Meeting, (2013)
  • "Bronchopulmonary dyslasia: development of a developmental therapy." American Academy of Pediatrics National Conference and Exhibition (2013)
  • "Clinical risk assessment in gastrointestinal stromal tumors." GI Cancer Dinner Symposium, (2013)
  • "Comparative benefits of nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer" 2013 Gastrointestinal Cancers Symposium (ASCO-GI) (2013)
  • "Establishment of multidisciplinary hepatocellular carcinoma clinic is associated with better clinical outcome" 2013 Gastrointestinal Cancers Symposium (ASCO-GI) (2013)
  • "Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer" 2013 Gastrointestinal Cancers Symposium (ASCO-GI) (2013)
  • "The quality of our quality reporting: metrics of cancer care following pancreatoduodenectomy" 2013 Gastrointestinal Cancers Symposium (ASCO-GI) (2013)
  • "Bevacizumab in metastatic colorectal cancer." Abilene Oncology Practice presentation,, Hendrick Cancer Center, (2012)
  • "Administration of Endothelial Monocyte Activating Polypeptide (EMAP II) function blocking antibody rescues alveolarization, decreases cellular proliferation and reduces apoptosis in bronchopulmonary dysplasia (BPD)" American Academy of Pediatrics Annual Meeting (2012)
  • "Heparanase inhibition reduces tumor growth and metastasis in pancreatic ductal adenocarcinoma by inducing hypoxia and inhibiting collagen deposition" American College of Surgeons (2012)
  • "nhibition of stromal TGFβR2 reduces pancreatic cancer growth and metastasis in vivo" American College of Surgeons (2012)
  • "Single-fraction stereotactic radiation of liver metastases: preliminary results of a phase I trial" American Society for Radiation Oncology (2012)
  • "Extrahepatic metastasis plus vascular invasion in patients with hepatocellular carcinoma portends a worse prognosis than extrahepatic metastasis or vascular invasion alone" International Liver Cancer Association ILCA Sixth Annual Conference (2012)
  • "Gastrointestinal cancer: an overview." UT Southwestern Department of Surgery Summer Grand Rounds Series, (2012)
  • "A phase II study of bavituximab and sorafenib in advanced hepatocellular carcinoma" American Society of Clinical Oncology Annual Meeting (2012)
  • "Clinical considerations for the treatment of GI stromal tumors." Arlington Cancer Center Grand Rounds, (2012)
  • "2G8, a TGFBR2 inhibitor, blocks TGF-B signaling and migration in an immunocompetent pancreatic cancer model" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Antitumor activity of BMS-754807, a small molecule inhibitor of insulin-like growth factor-1 receptor / insulin receptor, in combination with gemcitabine in pancreatic cancer" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Axl receptor tyrosine kinase is essential to pancreatic tumor progression and metastases" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Factors associated with perioperative outcomes following resection of retroperitoneal tumors" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Factors associated with readmission following complex hepato-pancreato-biliary operations" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Hepatocellular carcinoma in HIV-infected patients: a comparison of presentation, treatment and clinical outcomes with not HIVinfected patients" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "NVP-BEZ235, a dual PI3K/mTOR inhibitor, enhances chemotherapy and antiangiogenic response in pancreatic cancer" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation and migration in vitro and in vivo" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Potential factors to explain decreased survival of Blacks and Hispanics with gastroesophageal adenocarcinoma" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Multidisciplinary aspects of GI stromal tumor care." UT Southwestern 2nd Annual Gastrointestinal Cancer Symposium (2012)
  • "A phase I study of bavituximab and sorafenib in advanced hepatocellular carcinoma" American Association for Cancer Research (2012)
  • "An update on gastrointestinal cancer." Society of Surgical Oncology 65th Annual Cancer Symposium, (2012)
  • "Antitumor activity of BMS-754807, a small molecule inhibitor of insulin-like growth factor-1 receptor / insulin receptor, in combination with gemcitabine in pancreatic cancer" American Association for Cancer Research (2012)
  • "Apricoxib enhances response to standard therapy and promotes mesenchymal to epithelial transition in preclinical models of pancreatic cancer" 65th Annual Cancer Symposium, Society of Surgical Oncology (2012)
  • "Effect of 2G8, a TGF-beta-R2 inhibitor, on TGF-beta signaling and migration in an immunocompetent pancreatic cancer model" Society of Surgical Oncology 65th Annual Cancer Symposium (2012)
  • "Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition" 65th Annual Cancer Symposium, Society of Surgical Oncology (2012)
  • "Exploration of enhancing pancreatic cancer targeted combination therapy through antiendothelial EMAP II" Americas Hepato Pancreato Biliary Association 12th Annual Meeting (2012)
  • "Factors associated with readmission following complex hepato-pancreato-biliary operations" Americas Hepato Pancreato Biliary Association 12th Annual Meeting (2012)
  • "Initial experience with a comprehensive tissue biobanking program focusing on complex gastrointestinal cancer resections" Americas Hepato Pancreato Biliary Association 12th Annual Meeting (2012)
  • "NVP-BEZ235, a dual PI3K/mTOR inhibitor, enhances chemotherapy and antiangiogenic response in pancreatic cancer" Society of SurgicalOncology 65th Annual Cancer Symposium (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation in vitro and tumor progression in vivo" Society of Surgical Oncology 65th Annual Cancer Symposium (2012)
  • "Adjuvant therapy of gastrointestinal stromal tumors." Oncology group meeting, (2012)
  • "AXL receptor tyrosine kinase is critical to pancreatic cancer progression and metastases" 51st AXL receptor tyrosine kinase is critical to pancreatic cancer progression and metastases, Annual Meeting of the North Texas Chapter (2012)
  • "Axl receptor tyrosine kinase is essential to pancreatic tumor progression and metastases" 7th Annual Academic Surgical Congress (2012)
  • "Comparison of tissue preservation methods and resulting RNA quality in gastrointestinal tumors and associated benign tissues" 5th Annual Biospecimen Research Network (BRN) Symposium: Research Through Biospecimen Science (2012)
  • "Factors associated with perioperative outcomes following resection of retroperitoneal tumors" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Factors associated with readmission following complex hepato-pancreato-biliary operations" American College of Surgeons,, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Initial experience with a comprehensive tissue biobanking program focusing on complex gastrointestinal cancer resections" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation in vitro and tumor progression in vivo" 51st, Annual Meeting of the North Texas Chapter (2012)
  • "Plexiform neurofibromatosis of the liver" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Potential factors to explain decreased survival of Blacks and Hispanics with gastroesophageal adenocarcinoma" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Targeted therapy for c-kit positive GIST." Ochsner Medical Group Practice meeting, (2012)
  • "Effect of 2G8, a TGF-beta-R2 inhibitor, on TGF-beta signaling and migration in an immunocompetent pancreatic cancer model" 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "Evaluation of combination treatment benefits of nab-paclitaxel in experimental pancreatic cancer." 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "NVP-BEZ235, a dual PI3K/mTOR inhibitor, enhances chemotherapy and antiangiogenic response in pancreatic cancer" 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation in vitro and tumor progression in vivo" 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "Potential factors to explain decreased survival for ethnic subgroups with gastroesophageal adenocarcinoma (poster presentation," 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "The predictive value of POSSUM scoring in postoperative complications of patients with cancer and complex gastrointestinal surgical conditions" UT Southwestern Students Research Forum (2012)
  • "Current status and future projections of minimal-invasive procedures within surgical oncology (in German)." 20th Hamburg Minimal-Invasive Surgery Symposium (2011)
  • "Dosimetric and motion analysis of margin-intensive radiation delivery by stereotactic body radiation therapy for operable pancreatic cancer" American Society for Radiation Oncology (2011)
  • "Preclinical antitumor activity and mechanisms of action of apricoxib, a COX-2 inhibitor" 97th Annual Clinical Congress of the American College of Surgeons (2011)
  • "Kit + GIST rounds: imatinib mesylate for treatment of adjuvant and metastatic Kit+ GIST." Texas Oncology educational meeting (2011)
  • "Multidisciplinary therapy of GI stromal tumors." Arlington Cancer Center Grand Rounds (2011)
  • "Surgical Oncology for surgical residents: an introduction." UT Southwestern Department of Surgery Summer Grand Rounds Series, (2011)
  • "Analysis of quality parameters for early postoperative outcomes after hepatic resections" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Analysis of quality parameters for early postoperative outcomes after hepatic resections" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Current approaches to gastric cancer." First International Biennial of Oncology / Ex-Residents A.C. Camargo, First Congress of the Brazilian Society of Surgical Oncology (2011)
  • "Current status and future prospects for the treatment of gastrointestinal stromal tumors (GIST)." First International Biennial of Oncology, Ex-Residents A.C. Camargo First Congress of the Brazilian Society of Surgical Oncology (2011)
  • "Current status and future prospects of surgery for tumors of the pancreas." First International Biennial of Oncology, Ex-Residents A.C. Camargo First Congress of the Brazilian Society of Surgical Oncology (2011)
  • "Enhancement of chemotherapeutic efficacy by combination of targeted antiangiogennic therapies in experimental pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Malignant pancreatic cystic neoplasms: histopathologic subtypes and associated survival outcomes" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Margin-intense stereotactic irradiation as preoperative adjuvant therapy for pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "NVP-BEZ235, a novel dual PI3-Kinase/mTOR inhibitor, enhances antitumor combination therapy effects against pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Prospects in the management of colorectal cancer liver metastases." Preparations for the 2012 AHPBA Consensus Conference., First International Biennial of Oncology / Ex-Residents A.C. Camargo First Congress of the Brazilian Society of Surgical Oncology (2011)
  • "Smac mimetic improves response to gemcitabine and docetaxel in experimental pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Soft tissue sarcomas: clinical case discussions." First International Biennial of Oncology, Ex-Residents A.C. Camargo First Congress of the Brazilian Society of Surgical Oncology (2011)
  • "Total pancreatoduodenectomy with portal venous resection for locoregionally advanced pancreatic neuroendocine tumor." 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Augmentation of antiangiogenic therapies to enhance gemcitabine response in pancreatic cancer" American Association for Cancer Research (2011)
  • "Local therapies for liver-only colorectal cancer metastases: when and how" UT Southwestern Gastrointestinal Cancer Symposium, (2011)
  • "Perioperative treatment approaches to pancreatic cancer." UT Southwestern Gastrointestinal Cancer Symposium, (2011)
  • "Antitumor activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer" American Hepato Pancreato Biliary Association 11th Annual Meeting, March (2011)
  • "Antitumor activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer." American Hepato Pancreato Biliary Association 11th Annual Meeting, M (2011)
  • "Imatinib mesylate for treatment of adjuvant and metastatic kit+ GIST." Educational speaker program, (2011)
  • "Inhibition of COX-2 with apricoxib significantly enhances the efficacy of standard therapy in preclinical models of human pancreatic cancer" Society of Surgical Oncology's 64th Annual Cancer Symposium (2011)
  • "NVP-BEZ235, a novel dual PI3-Kinase/mTOR inhibitor, enhances antitumor combination therapy effects against pancreatic cancer" Society of Surgical Oncology's 64th Annual Cancer Symposium (2011)
  • "Surgical Oncology: aspects of a general surgical subspecialty." UT Southwestern Medical Center Wilson Society of medical students with an interest in Surgery. (2011)
  • "Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes" American Hepato Pancreato Biliary Association 11th Annual Meeting (2011)
  • "The impact of ethnic group background on presentation and outcomes for patients with gastroesophageal adenocarcinoma" Society of Surgical Oncology's 64th Annual Cancer Symposium (2011)
  • "Analysis of quality parameters for early postoperative outcomes after hepatic resections" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Attempts to enhance gemcitabine effects by antiangiogenic therapies in pancreatic cancer" 6th Annual Academic Surgical Congress (2011)
  • "Attempts to enhance gemcitabine effects by antiangiogenic therapies in pancreatic cancer." 6th Annual Academic Surgical Congress (2011)
  • "Initiation and early experience of a multispecialty approach to pelvic exenterations for cancer" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Malignant pancreatic cystic neoplasms: histopathologic subtypes and associated survival outcomes" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Margin-intense stereotactic irradiation as preoperative adjuvant therapy for pancreatic cancer" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Prediction of malignancy risk for patients with dominant splenic lesions" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Robotic assisted low anterior resection for a distal rectal cancer: a video presentation" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Smac mimetic improves response to gemcitabine and docetaxel in experimental pancreatic cancer" 6th Annual Academic Surgical Congress (2011)
  • "Total pancreatoduodenectomy with portal venous resection for locoregionally advanced pancreatic neuroendocrine tumor" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Use of the liver hanging maneuver for resection of a large adrenocortical carcinoma" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "A comparison of competing lymph node staging schemes in resectable biliary cancer" 2011 Gastrointestinal Cancers Symposium (2011)
  • "Activity of a novel dual PI3-Kinase/mTOR inhibitor NVP-BEZ235 to enhance antitumor activities of gemcitabine and EMAP II in pancreatic cancer" 2011 Gastrointestinal Cancers Symposium (2011)
  • "Inhibition of COX-2 with apricoxib significantly enhances the efficacy of standard therapy in preclinical models of human pancreatic cancer" 2011 Gastrointestinal CancersSymposium (2011)
  • "Managing GI malignancies - a surgical update" CME presentation series, John Peter Smith Health Network, (2010)
  • "Regional therapy strategies for upper gastrointestinal malignancies." Surgical Oncology Program of the 59th Annual Clinical Meeting of the New Jersey Chapter, American College of Surgeons (2010)
  • "Cystic pancreatic lesions." Lubbock Crosby Garza County Medical Society Fall Symposium on Cancer Prevention (2010)
  • "Enhancing cytotoxic agent activity through EMAP II combination therapy in experimental pancreatic cancer" Cancer prevention and research Institute of Texas Innovations in Cancer Prevention and Research Conference (2010)
  • "Kit-positive GI stromal tumor rounds." DHAT and TDDC Gastroenterology Education Dinner (2010)
  • "Preoperative therapy for pancreatic cancer: support in favor of." Great Debates in Surgical Oncology Session, American College of Surgeons Meeting (2010)
  • "Antiendothelial combination therapy of pancreatic cancer" UT Southwestern Experimental Imaging Working Group (2010)
  • "Operative and multimodality strategies for hepatic colorectal cancer metastases." UT Southwestern Medical Oncology Fellows meeting (2010)
  • "Combination treatment benefits of EMAP II with doxorubicin, docetaxel and gemcitabine in experimental pancreatic cancer" 12th Annual UT Southwestern Surgical Research Forum (2010)
  • "Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral procedures" 12th Annual UT Southwestern Surgical Research Forum. (2010)
  • "Pancreatic cancer - an update." Moncrief Cancer Center Symposium (2010)
  • "Prediction of malignancy risk for patients with splenic mass lesions (poster presentation" 12th Annual UT Southwestern Surgical Research Forum (2010)
  • "Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes" 12th Annual UT Southwestern Surgical Research Forum (2010)
  • "A comparison of competing lymph node staging schemes in resectable biliary cancer" 9th World Congress of the International Hepato-Pancreato-Biliary Association IHPBA (2010)
  • "Combination treatment benefits of EMAP II with doxorubicin, docetaxel and gemcitabine in experimental pancreatic cancer" American Association for Cancer Research 101st Annual Meeting (2010)
  • "Pancreatic neoplasms." Lubbock Crosby Garza County Medical Society Spring Symposium on Cancer Prevention (2010)
  • "A combination approach to enhance taxane-based antitumor activity in experimental pancreatic cancer" 63rd Annual Cancer Symposium, Society for Surgical Oncology (2010)
  • "A comparison of competing lymph node staging schemes in resectable gastric cancer" Society for Surgical Oncology, 63rd Annual Cancer Symposium (2010)
  • "Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer" 63rd Annual Cancer Symposium, Society for Surgical Oncology (2010)
  • "Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?" Society for Surgical Oncology 63rd Annual Cancer Symposium (2010)
  • "Should medical students do research?" UT Southwestern Medical Student Wilson Society (2010)
  • "Case report of leiomyosarcoma of the inferior vena cava in a Jehovah’s Witness" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer" 5th Annual Academic Surgical Congress (2010)
  • "Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer." 5th Annual Academic Surgical Congress (2010)
  • "Effects of combination of EMAP II with doxorubicin, docetaxel, oxaliplatin and gemcitabine to enhance antitumor activity in pancreatic cancer" 5th Annual Academic Surgical Congress (2010)
  • "Effects of combination of EMAP II with doxorubicin, docetaxel, oxaliplatin and gemcitabine to enhance antitumor activity in pancreatic cancer." 5th Annual Academic Surgical Congress, (2010)
  • "Effects of the Smac Mimetic JP1201 to enhance antitumor activities of gemcitabine and EMAP II in experimental pancreatic cancer" 5th Annual Academic Surgical Congress (2010)
  • "Effects of the Smac Mimetic JP1201 to enhance antitumor activities of gemcitabine and EMAP II in experimental pancreatic cancer." 5th Annual Academic Surgical Congress, (2010)
  • "Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral procedures" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Graded histologic response after neoadjuvant chemoradiotherapy and surgical resection for gastroesophageal junction cancer" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Intraduodenal sarcoma recurrence: an unusual cause for duodenal obstruction" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Liver resection improves survival for non-metastatic gallbladder cancer: a 10-year review" 2010 Gastrointestinal Cancers Symposium (2010)
  • "Operative therapy of adrenocortical carcinoma with right atrial thrombus extension: a case report" Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Positron emission tomography is beneficial in the preoperative evaluation of patients with colorectal cancer recurrences" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "A comparison of competing lymph node staging schemes in resectable gastric cancer" 2010 Gastrointestinal Cancers Symposium (2010)
  • "Utility of hepatic resection and systemic therapy for colorectal cancer liver metastases." Texas Oncology Practice Meeting (2009)
  • "Multimodality therapy for colorectal cancer liver metastases." Wise Regional Health System CME Lecture, (2009)
  • "Pancreatic cancer: an update" Midland Memorial Hospital CME Lecture (2009)
  • "Finding an answer to pancreatic cancer." City of Hope National Cancer Center Surgical Grand Rounds, (2009)
  • "Colorectal cancer liver metastases: a multidisciplinary approach." Medical oncology practice meeting, (2009)
  • "11th UT Southwestern Surgical Research Forum" 11th UT Southwestern Surgical Research Forum (2009)
  • "An update on pancreatic cancer therapy" Gastroenterological Clinical Practice Meeting (2009)
  • "Impact of clinical and diagnostic characteristics on a surgical approach to retroperitoneal mass lesions" 11th UT Southwestern Surgical Research Forum (2009)
  • "Operative predictors of early postgastrectomy outcomes, and their impact on long-term survival" 11th UT Southwestern Surgical Research Forum (2009)
  • "Survival impact of malignant pancreatic islet cell neoplasm phenotypes" Digestive Disease Week (2009)
  • "The role of ethnic, economic, and insurance disparities in the outcome of patients with colorectal adenocarcinoma" 11th UT Southwestern Surgical Research Forum (2009)
  • "Advances in the management of colorectal cancer liver metastases." (2009)
  • "Advances in the management of colorectal cancer liver metastases: the need for a multidisciplinary approach." Associates in Medical Oncology (2009)
  • "Improving the treatment for colorectal cancer liver metastases - a multidisciplinary approach." JOHA Oncology Practice (2009)
  • "American Hepato-Pancreato-Biliary Association 2009 Annual Meeting" Arlington Cancer Center (2009)
  • "Effect of bortezomib to enhance antitumor effects of gemcitabine and EMAP II in pancreatic cancer" American Association for Cancer Research (2009)
  • "Improving the treatment for colorectal cancer liver metastases – a multidisciplinary approach." Metaire Oncology Group (2009)
  • "Improving the treatment for colorectal cancer liver metastases – a multidisciplinary approach." Tulane University Cancer Center Conference (2009)
  • "Improving the treatment for colorectal cancer liver metastases – a multidisciplinary approach." Meridian Regional Hospital Tumor Board Meeting (2009)
  • "Improving the treatment for colorectal cancer liver metastases – a multidisciplinary approach." The University of Mississippi University Cancer Center GI Group meeting, (2009)
  • "Management of colorectal cancer liver metastases." Current Topics in General Surgery CME Course,, UT Southwestern Medical Center (2009)
  • "Pancreatic cystic neoplasms: histopathologic diagnoses and resulting survival outcomes" American Hepato-Pancreato-Biliary Association 2009 Annual Meeting (2009)
  • "Proteasome inhibition in combination therapy of experimental pancreatic cancer: in vitro and in vivo evaluation" American Hepato-Pancreato-Biliary Asociation 2009 Annual Meeting (2009)
  • "Proteasome inhibition in combination therapy of experimental pancreatic cancer: in vitro and in vivo evaluation." American Hepato-Pancreato-Biliary Association 2009 Annual Meeting (2009)
  • "Routine nasogastric decompression is unnecessary after pancreatic resection" American Hepato-Pancreato-Biliary Association 2009 Annual Meeting (2009)
  • "An antiendothelial combination strategy to increase survival in experimental pancreatic cancer" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "An antiendothelial combination strategy to increase survival in experimental pancreatic cancer." Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Impact of clinical and diagnostic characteristics on a surgical approach to retroperitoneal mass lesions" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Inhibition of the anti-angiogenic protein EMAP II enhances wound healing" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Liver resection improves survival for non-metastatic gallbladder cancer: a 10 year review" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Operative predictors of early postgastrectomy outcomes, and their impact on long-term survival" 48th Annual Meeting of the North Texas Chapter of the American College of Surgery (2009)
  • "Operative predictors of early postgastrectomy outcomes, and their impact on long-term survival" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Routine nasogastric decompression is unnecessary after pancreatic resection" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "The role of ethnic, economic, and insurance disparities in the outcome of patients with colorectal adenocarcinoma" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Visceral organ resections combined with synchronous major hepatectomy: feasibility and outcomes" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "A multidisciplinary approach to gastric cancer." Department of Radiation Oncology Educational Conference,, UT Southwestern Medical Center (2009)
  • "Continued antiendothelial combination therapy improves long-term survival in experimental pancreatic cancer" 2009 ASCO Gastrointestinal Cancers Symposium (2009)
  • "Mastering clinical challenges in pancreatic cancer." RHD Memorial Medical Center Monthly CME Event (2009)
  • "Survival impact of malignant solid histopathologic neoplasm subtypes in the exocrine pancreas" 2009 ASCO Gastrointestinal Cancers Symposium (2009)
  • "Advances in the management of colorectal cancer liver metastases." (2008)
  • "Multidisciplinary management of colorectal cancer metastases." Medical Oncology Group Meeting, (2008)
  • "A UT Southwestern GI Cancer Program: challenges and opportunities." Department of Medicine Grand Rounds, UT Southwestern Medical Center (2008)
  • "An update on pancreatic cancer." Board of Visitors Meeting, UT Southwestern Medical Center (2008)
  • "Multidisciplinary management of colorectal cancer metastases" Medical Oncology Group Meeting, (2008)
  • "The UT Southwestern GI Cancer Program." Department of Surgery Grand Rounds, UT Southwestern Medical Center (2008)
  • "Therapeutic options for colorectal cancer liver metastases." Commanche Memorial Hospital CME Event (2008)
  • "Advances in the management of colorectal cancer liver metastases." Mercy Medical Center (2008)
  • "Advances in the management of colorectal cancer liver metastases." Community Oncology Seminar (2008)
  • "Gastric cancer: novel multidisciplinary strategies" Midland Memorial Hospital, (2008)
  • "Operative procedures for gastrointestinal cancer." AAPC meeting,, UT Southwestern Medical Center (2008)
  • "Therapeutic options for colorectal cancer liver metastases." Christ St. Michael Medical Center (2008)
  • "Basic Surgical Science Lecture: Gastrointestinal Cancer" UT Southwestern Medical Center,, UT Southwestern Medical Center (2008)
  • "Extended left-sided pancreatectomy with splenic vessel resection, but spleen-preservation" 10th Annual UT Southwestern Department of Surgery Surgical Research Forum (2008)
  • "Management of pancreatic lesions." Parkland Surgical Society 27th Annual Meeting (2008)
  • "Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison" 10th Annual UT Southwestern Department of Surgery Surgical Research Forum (2008)
  • "Visceral organ resections combined with synchronous major hepatectomy: feasibility and outcomes" 10th Annual UT Southwestern Department of Surgery Surgical Research Forum (2008)
  • "Gastric Cancer: US versus the rest of the world." Department of Surgery Grand Rounds, UT Southwestern Medical Center (2008)
  • "Role of lymphadenectomy for gastrointestinal cancer." Current Topics in General Surgery CME Course,, UT Southwestern Medical Center (2008)
  • "Endothelial monocyte activating polypeptide II interferes with VEGF induced angiogenesis mechanism" American Association for Cancer Research (2008)
  • "Pancreatic cancer treatment: surgical components of multidisciplinary care." 5th Symposium on Combined Modality Treatment, (2008)
  • "Exploration of anti-VEGF mechanisms in experimental pancreatic cancer" American Hepato-Pancreato-Biliary Association 2008 Annual Meeting (2008)
  • "Exploration of anti-VEGF mechanisms in experimental pancreatic cancer." American Hepato-Pancreato-Biliary Association 2008 Annual Meeting, (2008)
  • "Clinical challenges in pancreatic cancer." Hendrick Regional Medical Center Monthly CME Event (2008)
  • "Extended left-sided pancreatectomy with spleen preservation" Association for Academic Surgery 3rd Annual Academic Surgical Congress (2008)
  • "Extended left-sided pancreatectomy with splenic vessel resection, but spleen-preservation" 47th Meeting of the American College of Surgeons, North Texas Chapter (2008)
  • "Mechanism of EMAP II-mediated inhibition of VEGF induced angiogenesis" Association for Academic Surgery 3rd Annual Academic Surgical Congress (2008)
  • "Mechanism of EMAP II-mediated inhibition of VEGF induced angiogenesis." Association for Academic Surgery 3rd Annual Academic Surgical Congress, (2008)
  • "Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison" 47th Annual Meeting of the American College of Surgeons, North Texas Chapter (2008)
  • "Visceral organ resections combined with synchronous major hepatectomy: feasibility and outcomes" 47th Annual Meeting of the American Colleg of Surgeons, North Texas Chapter (2008)
  • "Surgical management of pancreatic cystic neoplasms." UT Southwestern 2nd Annual EndoTeam Course, (2008)
  • "Addressing clinical challenges of pancreatic cancer." Division of Gastroenterology Educational Conference, UT Southwestern Medical Center, (2007)
  • "Operative and biologic challenges in pancreatic cancer." Department of Surgery Postgraduate Course,, University of Iowa Medical Center (2007)
  • "Surgical Oncology Now and Then: Projections over Time." Department of Surgery Grand Rounds, UT Southwestern Medical Center, (2007)
  • "Angiogenesis-based combination therapy of pancreatic cancer" Hamon Center for Therapeutic Cancer Research Monthly Research Conference,, UT Southwestern Medical Center (2007)
  • "Experimental therapy of gastrointestinal cancers: combining separate mechanisms." Department of Surgery Research Conference, Dallas, UT Southwestern Medical Center (2007)
  • "UT Southwestern Surgical Oncology and GI Cancer Program Outline." UT Southestern Medical Center Medical Directors Meeting (2007)
  • "Enhancing gemcitabine-mediated effects against experimental pancreatic cancer via two antiangiogenic strategies." Division of Surgical Oncology Angiogenesis Lab Conference, UT Southwestern Medical Center, (2007)
  • "Clinical impact of lymphadenectomy extent in resectable esophageal cancer" Digestive Disease Week (2007)
  • "Clinical impact of lymphadenectomy extent in resectable esophageal cancer." Digestive Disease Week, (Society for Surgery of the Alimentary Tract) plenary session, (2007)
  • "Mastering surgical challenges in pancreatic cancer." Current Topics in General Surgery CME Course, UT Southwestern Medical Center (2007)
  • "The role of endoscopic ultrasound with fine-needle aspiration in guiding treatment of unusual hepatic cysts" Digestive Disease Week (2007)
  • "Enhancing gemcitabine-mediated effects against experimental pancreatic cancer via two antiangiogenic strategies" American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Enhancing gemcitabine-mediated effects against experimental pancreatic cancer via two antiangiogenic strategies." American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Factors influencing perioperative blood transfusions in patients undergoing major HPB procedures" American Hepato-Pancreato-Biliary Assicuatuib 2007 /abbyak Neetubg (2007)
  • "Factors influencing perioperative blood transfusions in patients undergoing major HPB procedures." American Hepato-Pancreato-Biliary Association 2007 Annual Meeting, (2007)
  • "Impact of local therapy for hepatocellular carcinoma on survival outcomes in the U.S. population" American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Impact of local therapy for hepatocellular carcinoma on survival outcomes in the U.S. population." American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Intrahepatic cholangiocarcinomas: treatment characteristics and results" American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Intrahepatic cholangiocarcinomas: treatment characteristics and results." American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Factors influencing perioperative blood transfusions in patients with gastrointestinal cancer" Association for Academic Surgery 2nd Annual Academic Surgical Congress (2007)
  • "Inhibition of fibronectin-dependent pancreatic cancer proliferation through EMAP II therapy." Association for Academic Surgery 2nd Annual Academic Surgical Congress, (2007)
  • "Inhibition of fibronectin-dependent pancreatic cancer proliferation through EMAP II therapy" Association for Academic Surgery 2nd Annual Academic Surgical Congress (2007)
  • "Impact of local therapy for hepatocellular carcinoma on survival outcomes in the U.S. population" 2007 ASCO Gastrointestinal Cancers Symposium (2007)
  • "Impact of local therapy for hepatocellular carcinoma on survival outcomes in the U.S. population." 2007 ASCO Gastrointestinal Cancers Symposium (2007)
  • "Pancreatic cancer: theses and projections." Department of Surgery Grand Rounds,, UMDNJ Robert Wood Johnson University Hospital (2006)
  • "Overview of medical student research." Valentine Mott Surgical Society, UMDNJ Robert Wood Johnson University Hospital, (2006)
  • "Surgical oncology: theses and projections." Roswell Park Cancer Institute Invited Lecturer Presentation, (2006)
  • "Biologic effects of antiandrogenic therapy of pancreatic cancer" New Jersey Annual Retreat on Cancer Research (2006)
  • "Extent of lymph node dissection and staging for extrahepatic cholangiocarcinomas: information from a large U.S. database" 2006 Annual Meeting, American Hepato-Pancreato-Biliary Association (2006)
  • "Extent of lymph node dissection and staging for extrahepatic cholangiocarcinomas: information from a large U.S. database." American HepatoPancreato-Biliary Association 2006 Annual Meeting, (2006)
  • "Therapeutic applications of EMAP II for anticancer therapy and other blood vessel dependent disease mechanisms." UMDNJ Intellectual Property Committee, UMDNJ Robert Wood Johnson University Hospital (2006)
  • "Androgen receptor blockade in experimental combination therapy of pancreatic cancer" Association for Academic Surgery 1st Annual Academic Surgical Congress (2006)
  • "Experimental EMAP II combination therapy of pancreatic cancer targeting tumor angiogenesis" Society of University Surgeons 1st Annual Academic Surgical Congress (2006)
  • "Experimental EMAP II combination therapy of pancreatic cancer targeting tumor angiogenesis." Society of University Surgeons 1st Annual Academic Surgical Congress (2006)
  • "Factors influencing change of preoperative treatment intent in patients with gastrointestinal cancer" Association for Academic Surgery 1st Annual Academic Surgical Congress (2006)
  • "Modal connections of nodal collections." Department of surgery Grand Rounds, UMDNJ Robert Wood Johnson University Hospital (2006)
  • "Liver and pancreas oncology." Janssen Pharmaceutica Medical Grand Rounds (2005)
  • "Exploring anti-endothelial cancer therapy: utility and mechanism." Department of Surgery Grand Rounds, UMDNJ Robert Wood Johnson University Hospital, (2005)
  • "Experimental combination therapy of pancreatic cancer targeting tumor angiogenesis" New Jersey Annual Retreat on Cancer Research (2005)
  • "Experimental combination therapy of pancreatic cancer targeting tumor angiogenesis." New Jersey Annual Retreat on Cancer Research (2005)
  • "Experimental combination therapy of pancreatic cancer" Cancer Institute of New Jersey, GI Cancer Program CCSG Group, (2005)
  • "Antiangiogenic combination treatment of experimental pancreatic cancer" 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Clinical impact of lymphadenectomy extent in resectable, advanced stage gastric cancer" 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Clinical impact of lymphadenectomy extent in resectable, advanced stage gastric cancer." 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Extent of lymphadenectomy for pancreatic cancer: information from a large U.S. database" 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Extent of lymphadenectomy for pancreatic cancer: information from a large U.S. database." 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Pancreatic cancer: challenges and program strategies" Cancer Institute of New Jersey Board of Overseers Meeting, (2005)
  • "Of surgical being and doing." Department of Surgery Grand Rounds,, UMDNJ Robert Wood Johnson University Hospital, (2004)
  • "Anticancer effects of the botanical PC-Hope extend beyond phytoestrogenic activity" 1st International Conferenceof the Society for Integrative Oncology (2004)
  • "Estrogen receptor beta / alpha ratio predicts pancreatic cancer cell response to estrogens" 38th Annual Meeting of the Association for Academic Surgery (2004)
  • "Responsiveness of pancreatic cancer cells to phytoestrogens: implications of estrogen receptor beta / alpha ratio" 1st International Conference of the Society for Integrative Oncology (2004)
  • "Responsiveness of pancreatic cancer cells to phytoestrogens: implications of estrogen receptor beta / alpha ratio." 1st International Conference of the Society for Integrative Oncology, (2004)
  • "Experimental pancreatic cancer therapy: exploring EMAP II" Cancer Institute of New Jersey Scientific Council Meeting (2004)
  • "Colorectal cancer liver metastases: surgical treatment concepts" Surgical Grand Rounds,, Muhlenberg Regional Medical Center (2004)
  • "Treatment of liver cancer." Advanced Practice Nurse Educational Lecture Series,, The Cancer Institute of New Jersey (2004)
  • "Pancreatic cancer – a clinical overview." Oncology fellows’ training conference, Cancer Institute of New Jersey (2004)
  • "In vitro and in vivo efficacy of the herbal mix PC-Hope on pancreatic cancer" 95th Annual Meeting of the American Association for Cancer Research (2004)
  • "In vivo antiendothelial EMAP-II therapy in a pancreatic cancer xenotransplant model" 95th Annual Meeting of the American Association for Cancer Research (2004)
  • "In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II" 57th Annual Cancer Symposium, Society of Surgical Oncology (2004)
  • "In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II." 57th Annual Cancer Symposium, Society of Surgical Oncology, (2004)
  • "Preoperative intratumoral adjuvant vaccination therapy for pancreatic cancer: a proposal." Cancer Institute of New Jersey Protocol Development Session (2004)
  • "Liver, surgical oncology style: cooked, frozen, or chopped." Department of Surgery Grand Rounds,, UMDNJ Robert Wood Johnson University Hospital (2004)
  • "α5ß1 integrin and mature Endothelial-Monocyte Activating Polypeptide II interactions alter fibronectin based endothelial cell adhesion (" 6th International Symposium on Antiangiogenic Agents (2004)
  • "Chinese herbal supplement PC-Hope extending survival in pancreatic cancer model" 2004 ASCO Gastrointestinal Cancers Symposium (2004)
  • "In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II" 2004 ASCO Gastrointestinal Cancers Sym (2004)
  • "Optimal number of lymph nodes dissected during gastrectomy for gastric cancer" 2004 ASCO Gastrointestinal Cancers Symposium (2004)
  • "Optimal number of lymph nodes dissected during gastrectomy for gastric cancer." 2004 Gastrointestinal Cancers Symposium (2004)
  • "Surgical oncology: liver and biliary tract." Department of Surgery Residents’ Lecture,, UMDNJ Robert Wood Johnson University Hospital, (2003)
  • "Pancreatic cancer treatment: a natural alternative" Cancer Institute of New Jersey Monthly Faculty Meeting, (2003)
  • "Gastric cancer: a case for adjuvant therapy." 2003 Annual Clinical Congress of the American College of Surgeons (2003)
  • "Diagnosis and therapy of pancreatic cancer: a surgeon’s view." Department of Surgery Residents’ Lecture, UMDNJ Robert Wood Johnson University Hospital (2003)
  • "Constitutive activation of Transforming Growth Factor-β Receptor signaling in human pancreatic carcinoma cells" 94th Annual Meeting of the American Association for Cancer Research (2003)
  • "PC-Hope mediated toxicity in pancreatic cancer cells: estrogenic implications" 2003 Annual Retreat on Cancer (2003)
  • "In vivo therapy of pancreatic cancer with the antiendothelial agent EMAP II" 2003Annual Retreat on Cancer Research (2003)
  • "Surgical considerations for multimodality treatment of pancreatic and gastric cancer." Raritan Bay Medical Center Grand Rounds (2003)
  • "Pancreatic cancer: what is important?" Department of Surgery Residents’ Lecture, UMDNJ Robert Wood Johnson University Hospital, (2003)
  • "Surgery of the liver and biliary tract" Department of Surgery Residents’ Lecture,, UMDNJ Robert Wood Johnson University Hospital (2003)
  • "Why should medical students do research?" Valentine Mott Surgical Society, UMDNJ Robert Wood Johnson University Hospital (2002)
  • "Gastric cancer: malignant roadblocks of the magenstrasse." Department of Surgery Grand Rounds, UMDNJ Robert Wood Johnson University Hospital (2002)
  • "Gastric cancer: surgical considerations relating to adjuvant therapy." The 2nd Princess Margaret Hospital Conference on New Developments in Cancer Management, (2002)
  • "Pancreatic cancer: current clinical status and future research directions." Cancer Institute of New Jersey Monthly Faculty Meeting (2002)
  • "Classification and surgical approach to GE junction tumors." Society of Surgical Oncology 55th Annual Cancer Symposium (2002)
  • "Paint only is equivalent to scrub and paint for the preoperative preparation of breast and axillary surgery sites" 55th Annual Cancer Symposium, Society of Surgical Oncology (2002)
  • "Quality of life in patients with colorectal metastasis and intrahepatic chemotherapy" 55th Annual Cancer Symposium, Society of Surgical Oncology (2002)
  • "Liver resections: indications, techniques, and outcomes." Department of Surgery Residents’ Lecture,, UMDNJ Robert Wood Johnson University Hospital, (2002)
  • "Surgery and adjuvant therapy for gastric carcinoma in the USA." 8th Aichi Cancer Center International Symposium, (2002)
  • "Pancreatic cancer: techniques, technicalities, and not so technical considerations." Department of Surgery Grand Rounds, UMDNJ Robert Wood Johnson University Hospital, (2002)
  • "Gastroesophageal cancer: essentials." Department of Surgery Residents’ Lecture,, UMDNJ Robert Wood Johnson University Hospital (2001)
  • "Pancreatic cancer: clinical challenges." Department of Surgery Residents’ Lecture,, UMDNJ Robert Wood Johnson University Hospital, (2001)
  • "Challenges of interpreting non-randomized intraoperative surgical data" Graybill Conference on Linear Models (2001)
  • "Recurrence patterns after gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy" 4th International Gastric Cancer Congress (2001)
  • "Recurrence patterns after gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy." 4th International Gastric Cancer Congress, (2001)
  • "Downregulation of tumor angiogenesis by antiendothelial treatment in vivo" 101st Annual Congress of the Japan Surgical Society (2001)
  • "Downregulation of tumor angiogenesis by antiendothelial treatment in vivo." 101st Annual Congress of the Japan Surgical Society, (2001)
  • "Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity" 4th International Gastric Cancer Congress (2001)
  • "Gastric carcinogenesis through tobacco chewing: in vitro mechanistic studies of DNA nitrite attack" 4th International Gastric Cancer Congress (2001)
  • "Additive toxicity through chinese herbal extracts SPES and PC-SPES in human pancreatic cancer" 92nd Annual Meeting, American Association for Cancer Research (2001)
  • "Outcome of palliative procedures for malignant bowel obstruction in patients with nongynecologic malignancy" 54th Annual Cancer Symposium, Society of Surgical Oncology (2001)
  • "Advanced age does not contribute to increased risks or poor outcome after major upper abdominal resections" American College of Surgeons Southern California Chapter Annual Meeting (2001)
  • "Resistance of human pancreatic cancer cell lines against basic fibroblast growth factor (bFGF)-mediated sensitization to cisplatin-induced cytotoxicity" International Association of Pancreatoogy and American Pancreatic Association Combined Meeting (2000)
  • "The toxic effects of Chinese herbal extracts SPES and PC-SPES on human pancreatic cancer cells" International Association of Pancreatology and American Pancreatic Association Combined Meeting (2000)
  • "Utilization and outcome of intraoperative radiation after pancreatectomy for pancreatic and periampullary cancer: a propensity score and CART analysis" International Association of Pancreatology and American Pancreatic Association Combined Meeting (2000)
  • "Gemcitabine-sensitized IORT for patients with cancer of the pancreas and other UGI sites" 2nd International Conference of the International Society of Intraoperative Radiation Therapy (2000)
  • "Pancreatic cancer: surgical and oncologic considerations." Department of Surgery Grand Rounds,, University of Arizona Medical Center, (2000)
  • "Pancreatic cancer: surgical considerations and beyond." Department of Surgery Grand Rounds, Martin Luther King Jr. / Charles R. Drew University Medical Center (2000)
  • "Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease and patient" 17th World Congress of the international Society for Digestive Surgery (2000)
  • "Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease and patient." 17th World Congress of the International Society for Digestive Surgery (2000)
  • "Gastrectomy circumstances that influence early postoperative outcome" 17th World Congress of the International Society for Digestive Surgery (2000)
  • "Preoperative platelet count predicts outcome after resection of periampullary adenocarcinoma" 17th World Congress of the International Society for Digestive Surgery (2000)
  • "The impact of intraoperative radiation on outcome after resection of periampullary adenocarcinoma" 17th World Congress of the International Society for Digestive Surgey (2000)
  • "The impact of intraoperative radiation on outcome after resection of periampullary adenocarcinoma." 17th World Congress of the International Society for Digestive Surgery (2000)
  • "Pancreatectomy and vascular resection: cutting edge or border to no-no-land?" Department of General Oncologic Surgery Educational Conference, City of Hope National Medical Center (2000)
  • "Enhancing toxicity mechanisms in pancreatic cancer: preclinical investigations." Cancer Institute of New Jersey Research Conference, University of Medicine and Dentistry of New Jersey (2000)
  • "Failure of epidermal growth factor (EGF) to sensitize human pancreatic cancer cells to cytotoxic chemotherapy" The Pancreas Club 34th Annual Meeting (2000)
  • "Intraoperative radiation for pancreatic adenocarcinoma: clinical results" The Pancreas Club 34th Annual Meeting (2000)
  • "In vitro pancreatic cancer toxicity of various chemotherapeutic agents is potentiated by wheatgerm agglutinin" 91st Annual Meeting American Association for Cancer Research (2000)
  • "In vivo therapy of local tumor progression by targeting vascular endothelium" 53rd Cancer Symposium Society of Surgical Oncology (2000)
  • "Esophageal cancer: diagnosis and therapy" Providence Holy Cross Medical Center (1999)
  • "Pancreatic cancer: is it a curable disease?" Antelope Valley Health Care System Seminar: Update in Cancer 1999, (1999)
  • "Periampullary cancer: surgical considerations." Mission Hospital Regional Medical Center CME Program (1999)
  • "Esophageal cancer: what the surgeon needs to consider." South Coast Medical Center Grand Rounds (1999)
  • "Long-term tunneled intravenous access in cancer patients: device-specific outcome" 52nd Cancer Symposium, Society of Surgical Oncology (1999)
  • "Surgical and multidisciplinary therapeutic options in pancreatobiliary neoplasia. Advances in the multidisciplinary treatment of hepatic and pancreaticobiliary neoplasms," City of Hope Comprehensive Cancer Center Symposium, (1999)
  • "A mortality-free decade of pancreatoduodenectomy: is quality independent of quantity?" Annual Scientific Meeting of the Southern California Chapter of the American College of Surgeons, (1999)
  • "Pancreatoduodenectomies over 10 years without mortality: quality rather than quantity" Southern California Chapter of the ACS Annual Scientific Meeting (1999)
  • "The multidisciplinary approach to esophageal cancer." Georgia Cancer Specialists “Meet the Professor” Lecture, (1998)
  • "The impact of splenectomy on outcome after resection of pancreatic adenocarcinoma" 39th Annual Meeting of the Society for Surgery of the Alimentary Tract (1998)
  • "Central lines: along which lines to go?" City of Hope National Medical Center Grand Rounds, (1998)
  • "Surgical advances in the treatment of esophageal cancer." Southern California Academy of Clinical Oncology meeting, (1998)
  • "Esophageal and gastric cancer: surgical considerations." 3rd Annual Conference of the National Comprehensive Cancer Network (1998)
  • "Gastric Cancer: NCCN Treatment Guidelines Presentation" 3rd Annual Conference of the National Comprehensive Cancer Network, (1998)
  • "Pancreatectomy and intraoperative radiation therapy for periampullary carcinoma: a 10-year experience at City of Hope." City of Hope Surgical Oncology Fellowship Alumni Meeting, (1998)
  • "Targeting p53 for adoptive T cell immunotherapy" 83rd Annual Clinical Congress, American College of Surgeons (1997)
  • "Enhanced effect of cytotoxic agents against pancreatic cancer cells in vitro through wheat germ agglutinin-induced apoptosis" American Society of Clinical Oncology Annual Meeting (1997)
  • "Gastric cancer masqueraded by metastatic breast cancer: a differential diagnostic challenge" 2nd International Gastric Cancer Congress (1997)
  • "Impact of complications on hospitalization and survival after operative treatment of gastric cancer in elderly patients" 2nd International Gastric Cancer Congress (1997)
  • "Impact of complications on hospitalization and survival after operative treatment of gastric cancer in elderly patients." 2nd International Gastric Cancer Congress (1997)
  • "Total gastrectomy is not necessary for proximal gastric cancer" 2nd International Gastric Cancer Congress (1997)
  • "Desmoplastic small round cell tumors (DSRCT): not just some high-grade sarcomas" 50th Cancer Symposium, Society of Surgical Oncology (1997)
  • "Desmoplastic small round cell tumors (DSRCT): not just some high-grade sarcomas." 50th Cancer Symposium, Society of Surgical Oncology (1997)
  • "Mechanism of wheat germ agglutinin-induced apoptosis of pancreatic cancer cells" 50th Cancer Symposium, Society of Surgical Oncology (1997)
  • "Mechanism of wheat germ agglutinin-induced apoptosis of pancreatic cancer cells." Society of Surgical Oncology,, 50th Cancer Symposium (1997)
  • "Novel concepts in the operative treatment of gastric cancer." Tarzana-Encino Medical Center, Grand Rounds, (1997)
  • "Lectin binding to pancreatic cancer cell membrane-associated carbohydrate results in toxicity and apoptosis." Surgical Oncology Forum, American College of Surgeons, 82nd Annual Clinical Congress, (1996)
  • "Lectin binding to pancreatic cancer cell membrane-associated carbohydrate results in toxicity and apoptosis." 82nd Annual Clinical Congress, American College of Surgeons (1996)
  • "Gastric cancer: a comprehensive outcome analysis based on a prospective database." Department of Surgery Grand Rounds,, University of Iowa Medical Center, (1996)
  • "Observations on lectin binding of pancreatic cancer cell lines." City of Hope National Cancer Center Surgical Research Conference, (1996)
  • "Endothelial monocyte-activating polypeptide 2: an antiangiogenic protein suppresses tumor growth by selectively inducing apoptosis of endothelium" 1996 AACR Meeting (1996)
  • "Phythemagglutinin-L surface binding of N-linked β1-6 carbohydrates and their relationship to activated mutant ras protein in human pancreatic cancer cell lines." 1996 AACR meeting (1996)
  • "Wheatgerm agglutinin-induced apoptosis as a mediator of in-vitro toxicity against pancreatic cancer." Department of Surgery Research Conference,, Memorial Sloan-Kettering Cancer Center, (1996)
  • "Elderly patients with gastric cancer: surgical and oncologic considerations." City of Hope National Cancer Center Surgical Conference, (1996)
  • "Subcutaneous central venous access devices in cancer patients" The Society of Surgical Oncology 49th Cancer Smposium (1996)
  • "Gastric cancer in the elderly: operation justified?" Department of Surgery GMT Conference, Memorial Sloan-Kettering Cancer Center, (1996)
  • "Survival benefit of extended lymphadenectomy for operable gastric cancer." Department of Surgery Clinical Debate, Memorial Sloan-Kettering Cancer Center, (1996)
  • "Endothelial Monocyte-Activating Polypeptide (EMAP) II, a novel antiangiogenic protein, suppresses tumor growth and induces apoptosis in endothelial cells." American Heart Association, 68th Scientific Sessions (1995)
  • "In-vitro response of pancreatic cancer cell lines to lectin binding" Division of Colorectal Surgery Laboratory Conference, Memorial Sloan-Kettering Cancer Center, (1995)
  • "Does preoperative biliary decompression reduce complications in patients undergoing curative resections?" Department of Surgery GMT Conference,, Memorial Sloan-Kettering Cancer Center, (1995)
  • "Does splenectomy influence survival of nonhematologic cancer?" Department of Surgery GMT Conference, Memorial Sloan-Kettering Cancer Center, (1995)
  • "A thoracoscopic approach to thoracic metastases and tumor recurrences." 48th Cancer Symposium of the Society of Surgical Oncology (1995)
  • "Inferior Vena cava filters in cancer patients: indications and outcome." The Society of Surgical Oncology 48th Cancer symposium (1995)
  • "Radiation-induced malignant tumors of the chest wall." The Society of Surgical Oncology 48th Cancer Symposium (1995)
  • "Use of IVC filtration in patients with cancer." Department of Surgery GMT Conference, Memorial Sloan-Kettering Cancer Center, (1995)
  • "Value of CEA surveillance after curative treatment of colorectal cancer" Department of Surgery Clinical Debate, Memorial Sloan-Kettering Cancer Center, (1995)
  • "Implications of the positive margin after lumpectomy." Department of Surgery Breast Conference,, Memorial Sloan-Kettering Cancer Center, (1994)
  • "Gastric Leiomyosarcomas." Department of Surgery GMT Conference,, Memorial Sloan-Kettering Cancer Center (1994)
  • "Gastrointestinal stromal neoplasms - a pathology review from a surgical standpoint." Department of Pathology Conference., Memorial Sloan-Kettering Cancer Center, (1994)
  • "Papillary tumors of the biliary tract" Department of Surgery GMT Conference, Memorial Sloan-Kettering Cancer Center, (1994)
  • "Parathyroid Cancer." Department of Surgery GMT Conference, Department of Surgery GMT Conference (1994)
  • "Special considerations for the treatment of breast cancer in the elderly." Department of Surgery Breast Conference, Memorial Sloan-Kettering Cancer Center, (1994)
  • "A thoracoscopic approach to thoracic metastases and tumor recurrences." European Society of Surgical Oncology Joint Meeting (1994)
  • "The application of thoracoscopic techniques to the management of intrathoracic metastases." European Society of Surgical Oncology Joint Meeting (1994)
  • "Gastrointestinal manifestations of post-transplant lymphoproliferative disease." Department of Surgery Grand Rounds, University of Pittsburgh (1994)
  • "The application of thoracoscopic techniques to the management of intrathoracic metastases." 47th Cancer Symposium, The Society of Surgical Oncology (1994)
  • "Thoracoscopic techniques in the management of intrathoracic metastases." Society of Surgical Oncology 47th Annual Cancer Symposium (1994)
  • "Gastric cancer: how to resect and how to reconstruct." Department of Surgery Journal Club, University of Pittsburgh (1994)
  • "Gastric sarcoma." Department of Surgery Grand Round Case Presentations, University of Pittsburgh (1994)
  • "Needle-localized thoracoscopic resections of small pulmonary nodules in patients before and after liver transplantation." 2nd Congress of the International Liver Transplantation Society (1993)
  • "New strategies for endocrine tumors." University of Pittsburgh Endocrine Surgery Conference (1993)
  • "Small bowel: the Roux-en-Y syndrome." Department of Surgery Journal Club, University of Pittsburgh (1993)
  • "Surgical considerations in metastatic esophageal cancer." University of Pittsburgh Visiting Professor Clinical Conference (1993)
  • "Achalasia and esophageal perforation" University of Pittsburgh Digestive Disease Grand Rounds (1993)
  • "Primary and secondary pulmonary nodules." Department of Surgery Grand Rounds Case Presentations, University of Pittsburgh (1993)
  • "Lung masses of unclear benignancy and staging: improved diagnosis and therapy with thoracoscopic resection." German Surgical Society, 110th Annual Meeting (1993)
  • "Lung masses of unclear benignancy and staging: improved diagnosis and therapy with thoracoscopic resection." 110th Annual Meeting of German Surgical Society (1993)
  • "Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant disease." 46th Annual Cancer Meeting, Society of Surgical Oncology (1993)
  • "Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant disease." Society of Surgical Oncology Annual Meeting 1993 (1993)
  • "Breast cancer; the early breast cancer trialists metaanalysis." Department of Surgery Journal Club, University of Pittsburgh (1993)
  • "Vascular Tumors in the neck" Department of Surgery Grand Rounds Case Presentations, University of Pittsburgh (1992)
  • "Megacolon and volvulus." Department of Surgery Journal Club, University of Pittsburgh (1992)
  • "Megacolon and volvulus." Department of Surgery Journal Club, University of Pittsburgh (1992)
  • "Management of locally advanced breast cancer" Department of Surgery Grand Round Case Presentations, University of Pittsburgh (1992)
  • "Carotid body tumors." Department of Otorhinolaryngology Clinicval Conference, University of Pittsburgh (1992)
  • "Tracheostomy versus long-term intubation" Department of Surgery Journal Club, University of Pittsburgh (1991)
  • "Ovarian Vein Thrombophlebitis" Department of Surgery Grand Rounds Case Presentations, University of Pittsburgh (1991)
  • "CNS Trauma" University of Pittsburgh Journal Club, Department of Surgery (1991)
  • "Tension Pneumoperitoneum" Department of Surgery Journal Club, University of Pittsburgh (1991)
  • "Cystic and papillary Pancreatic Cancer" University of Pittsburgh GI Conference (1991)
  • "Pseudotumor of the liver" University of Pittsburgh, Department of Surgery Grand Rounds Presentation (1991)
  • "Mesenteric Cysts" University of Pittsburgh GI Conference (1990)
  • "Experimental adoptive therapy of hepatic metastases: a comparison of systemic and locoregional administration." German Surgical Society, 107th Annual Meeting (1990)
  • "Effects of splenectomy for adoptive immunotherapy on the tumor bearing host." Association for Academic Surgery, 23rd Annual Meeting (1989)
  • "Organ-associated development of Interleukin2-induced specific immunity against mammary adenocarcinoma." 23rd Annual Meeting of the Association for Academic Surgery (1989)
  • "Regulation of Kupffer-cell-mediated antitumor activity in vitro by IL-2-activated Natural Killer cells." Society for Biological Therapy Annual Meeting (1989)
  • "Biologic properties and antitumor function of human adherent lymphokine-activated killer (A-LAK) cells." 7th International Congress of Immunology (1989)
  • "Functional analysis of antigen-receptor structures shared by natural killer (NK) cells and lymphokine-activated killer (LAK) cells." 7th International Congress of Immunology (1989)
  • "In-vitro production and serum levels of tumor necrosis factor-alpha in patients with HIV infections." 7th International Congress of Immunology (1989)
  • "Influence of previous anticancer therapy on in-vitro generation of human adherent lymphokine-activated killer (A-LAK) cells." 7th International Congress of Immunology (1989)
  • "Successful adoptive immunotherapy of established lung and liver metastases with highly purified IL-2-activated natural killer (NK) cells." International NK-Workshop (1989)
  • "Antimetastatic effects of splenectomy and lymphokine-activated killer cells purified by their adherence to plastic (A-LAK cells)." Eightieth Annual AACR Meeting (1989)
  • "Antitumor cytotoxicity and other biologic properties of human adherent lymphokine-activated killer (A-LAK) cells." Eightieth Annual AACR Meeting (1989)
  • "Factors correlated with the generation of adherent lymphokine-activated killer cells (A-LAK) in patients with metastatic melanoma and renal cell cancer." ASCO Annual Meeting (1989)
  • "A 48 kD laminin-like receptor is involved in tumor cell antigen recognition by IL-2 activated non-MHC-restricted T cells and NK cells." 73rd Annual FASEB meeting (1989)
  • "LAK cells: molecules, cells and mechanisms involved in their antitumor activity." 73rd Annual FASEB Meeting (1989)
  • "P48: a surface structure involved in target cell recognition by non-MHC-restricted cytotoxic effector cells." 4th International Conference on Leukocyte Differentiation Antigens. (1989)
  • "A sulfated glycolipid is involved in lytic interactions between non-MHC-restricted cytotoxic effector cells and their targets." 73rd Annual FASEB meeting (1989)
  • "Growth and functional characteristics of human anti-tumor effector populations activated with IL-2." University of Pittsburgh, Immunology Research Conference (1988)
  • "In-vitro generation and anti-tumor cytotoxicity of adherent LAK (A-LAK) cells from the blood of patients with solid tumors." 3rd Annual Conference on Clinical Immunology, The Clinical Immunology Society (1988)
  • "A laminin B-2-chain- crossreactive surface structure (human p48 equivalent) is involved in target cell recognition by human non-MHC-restricted Interleukin-2-activated T lymphocytes." XX Annual Meeting of the "Gesellschaft fur Immunologie" (1988)
  • "Generation of LAK cell activity and enrichment in the most active, plastic adherent (A-LAK) effector cells in patients with malignant liver tumors." Ninth European Immunology Meeting (1988)
  • "Enhanced antimetastatic efficacy of lymphokine activated killer cells purified by their adherance to plastic (A-LAK cells)." Annual FASEB-Meeting (1988)
  • "Enhanced in vivo and in vitro antitumor efficacy of highly purified plastic adherent lymphokine activated killer cells (ALAK cells)." AACR (1988)
  • "Functional and phenotypic analysis of tumor infiltrating lymphocytes isolated from human liver tumors and cultured in rIL-2." Annual FASEB-Meeting (1988)
  • "Functional and phenotypic characteristics of adherent lymphokine-activated killer (A-LAK) cells from patients with malignant liver and central nervous system (CNS) tumors." 19th International Leukocyte Culture Conference (1988)
  • "Laminin B2 chain (p48 protein) is involved in tumor cell recognition by both Leu19+/CD3- and Leu19+/CD3- lymphokine-activated killer cells." 19th International Leukocyte Culture Conference (1988)
  • "The generation of purified adherent lymphokine-activated killer (ALAK) cells in patients with benign and malignant liver tumors." Annual FASEB-Meeting (1988)
  • "The laminin B2 chain (p48 protein): A functional role in cytotoxicity by highly purified Leu19+ human NK/LAK cells." V. Annual NK-Workshop (1988)
  • "Enhanced anti-metastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic." Ninth European Immunology Meeting (1988)
  • "Role of laminin B2 chain (p48 protein) in tumor cell recognition by highly purified Leu19+ lymphokine activated killer cells." Annual FASEB-Meeting (1988)
  • "The influence of laminin and anti-laminin on cytolytic function and proliferation of NK and LAK cells." Ninth European Immunology Meeting (1988)
  • "Tumor necrosis factor-alpha serum levels and in vitro production in patients with HIV infection" 73rd Annual FASEB meeting (1987)
  • "Perioperative systemic therapy for liver metastases from colorectal cancer." Mercy Health System Cancer Center
See all (597 more)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (214) 537-0498
roderich@buffalo.edu